Clinical Programs

Antipodean is working closely with the US and Australasian regulatory authorities, patient support groups and key physicians to design and conduct clinical study programs to establish the clinical efficacy of its lead product candidate, MitoQ®, in diseases of mitochondrial dysfunction.

Clinical Programs

For a full list of clinical work being done on MitoQ please click here

Such dysfunction can lead to liver inflammation as measured by elevation of liver enzymes and eventually cell death (apoptosis).